Changing Trends in Opioid Use among U.S. Rheumatoid Arthritis Patients
Conclusion
In the US, opioid use peaked in older RA patients in 2010 and is now declining slightly. Withdrawal of propoxyphene from the U.S. market in 2010 had minimal effect on overall use, as it was replaced with greater use of other opioids. This article is protected by copyright. All rights reserved.
Source: Arthritis and Rheumatism - Category: Rheumatology Authors: Jeffrey R Curtis, Fenglong Xie, Christian Smith, Kenneth G. Saag, Lang Chen, Timothy Beukelman, Melissa Mannion, Huifeng Yun, Stefan Kertesz Tags: Full Length Source Type: research
More News: Anxiety | Arthritis | Back Pain | Chronic Pain | Depression | Fibromyalgia | Hydrocodone | Medicare | Pain | Propoxyphene | Rheumatoid Arthritis | Rheumatology | Tramadol